DOW INC. (DOW): what the price assumes

boothcheck covers DOW INC. (DOW) but does not put one priced-in number on it: here the defensible answer is the evidence rather than a point estimate. boothcheck publishes no house fair value, target price, or buy/sell rating. Narrative composed 2026-07-25.

Generated: 2026-08-30 · Source: https://boothcheck.com/report/DOW

Headline

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

The operating-margin figure is value-band context at year 12: derived from the framework's value band, a separate calculation — not part of the priced-in solve.

How unusual the bet is: n/a

Valuation X-Ray

Every valuation family lands below the price. The price therefore sits beyond what those standard frames encode.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

Families that call it expensive: Asset, Growth

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 5.4%); the inversion above states its own rate.

Per-Model Detail (n=3)

Economic-Unit Decomposition (Sum Of The Parts)

One or more material disclosed units has unresolved economics. Unknown/general is not evidence of homogeneity: segment SOTP is primary but incomplete, consolidated cash flow may remain only a secondary cross-check when every unit shares an enterprise basis, and one sector multiple or target margin is withheld.

No total common-equity value is stated. One or more material units lack a supported unit value. The displayed values are an indicative subtotal; consolidated debt and cash cannot be applied to a fraction of the company.

Solvency

Leverage and coverage are computed on normalized mid-cycle operating income (mid-cycle margin 3.6%); the trailing year was depressed.

Bullet Takeaways

• This is an industry trough rather than a company failure, and the annual report says so in one line: Local price decreased across all operating segments and geographic regions driven by industry supply and demand dynamics and lower global energy and feedstock costs.
• The payout has been halved, with $0.35 declared per share in the March 2026 quarter against $0.70 a year earlier, which is management choosing the balance sheet over the cheque.
• Watch the joint ventures rather than the plants: equity losses inside the industrial intermediates business reached $242 million in the March quarter against $58 million a year earlier, and that line is doing more damage right now than the chemical price deck is.

Bull Case

Direction matters more than level in a commodity business, and the direction that counts is not Dow's earnings line. It is the industry's price line. Selling prices fell across every segment and every geography last year, and the 10-K attributes it to supply and demand across the industry alongside cheaper energy and feedstock, with packaging and specialty plastics down 8 percent on local price and industrial intermediates down 6 percent. The peer group tells the same story from five different balance sheets. LYB ran a negative 1.0% operating margin, WLK negative 15.7%, CE negative 7.8%, OLN negative 1.7% and HUN negative 3.3%. When an entire cohort loses money on operations simultaneously, the explanation is capacity, not management.

Into that, Dow has been cutting. The 10-K reports that Selling, general and administrative ("SG&A") expenses were $1,392 million in 2025, compared with $1,581 million in 2024. On July 7, 2025 the company announced additional restructuring actions, approved by the board on June 30, 2025, to rationalize its global asset footprint, and the March 2026 filing describes a broader program aimed at simplifying how the company operates and reengineering its cost structure. Costs taken out at the bottom of a cycle stay out when prices recover, which is the whole mechanism by which a chemical company makes money on the way up.

Volume is already turning in places. The 10-K expects continued volume growth in packaging and specialty plastics from global polyethylene demand and from the full-year benefit of a new polyethylene train on the U.S. Gulf Coast that came online in the second half of 2025. In the March 2026 quarter, currency added about 3 percent to net sales and volume rose 9 percent in Latin America, while performance materials and coatings saw local price rise 2 percent. A price increase anywhere in this industry right now is worth noticing.

Look at the March quarter by segment and the operating base is not broken. Packaging and specialty plastics produced $208 million of segment operating profit on Dow's own reported measure, performance materials and coatings $117 million, and industrial intermediates a loss of $118 million, netting to $154 million after corporate costs. The company's plants made money in a quarter widely described as the worst part of the cycle.

Management has also bought itself time deliberately. It sold membership interests in its Diamond Infrastructure Solutions business during 2025, which is why third-party interests on the balance sheet climbed to $1,514 million from $507 million, and it halved the dividend rather than borrow to defend it. Liquid assets stand near 4.1 billion dollars. The bull case does not require a fast recovery. It requires the company to still be standing when the recovery arrives, and the last twelve months of decisions were all aimed at exactly that.

Bear Case

A chemical company can look cheap on normalized earnings and still be expensive, because "normalized" is a decision somebody makes rather than something the accounts report. Everything favourable about this price rests on treating the present as the trough and the through-the-cycle figure as the truth. The accounts themselves offer no support for that yet. The 10-K states the result plainly: Net income (loss) available for Dow Inc. and TDCC common stockholder(s) was a loss of $2,623 million and $2,598 million, respectively, in 2025, compared with income of $1,116 million and $1,127 million, respectively, in 2024. That is a loss of $3.70 per share in a single year, and the March 2026 quarter widened rather than narrowed: a loss of $533 million available to common stockholders against $307 million a year earlier.

Now the price. There is no family of valuation method that reaches it. Book value plus profitability lands below, the comparable-multiple lenses land below, and the forward lenses land below as well. Book value stands at $21.14 a share against a market price of $29.85. Read on the company's own through-the-cycle margins of about 3.6% applied to current revenue, the market is paying roughly twenty-four times that normalized operating profit, and holding that price requires around 5.7% annual growth in it for five years. That growth has to come out of an industry that just cut its selling prices in every segment and every region.

Leverage is what turns a slow recovery into a real problem. Gross borrowings run near 16.3 billion dollars against liquid assets near 4.1 billion dollars, and net borrowings work out to about 8.4 times operating profit, measured through the cycle rather than on the trailing year. On that same normalized basis, operating profit covers interest only about 1.7 times. Note the word normalized twice in that sentence: on the trailing twelve months the company recorded a pre-tax loss of roughly 1.35 billion dollars, so the actual coverage over the past year was not positive at all. The 1.7 figure describes a mid-cycle world, not the one the company is currently in.

The joint ventures are the acute problem, and they are the one part of the business a cost programme cannot fix. Inside industrial intermediates, equity losses reached $242 million in the March 2026 quarter against $58 million a year earlier, and the filing links the deterioration in that business to declining licensing revenue and the impact of the conflict in the Middle East. Segment net sales there fell to $2,626 million from $2,855 million. Dow owns stakes it does not operate, in a region whose politics it does not control, and those stakes are currently losing four times what they lost a year ago.

Then the dividend. Declared payout fell to $0.35 a share in the March quarter from $0.70, and cash actually paid to holders fell to $252 million from $494 million. Cutting a dividend is a rational act, and it is also information: the board did not believe the cash it once expected was going to be there. Holders who owned this for the yield have already been told what management thinks of the recovery timetable.

There is a floor, though a modest one. Dow carries roughly 1.4 billion dollars of equity stakes held outside its operating segments, close to 6% of the company's market value, and those retain value independently of what happens to polyethylene spreads. It bounds the downside. It does not answer the leverage.

Valuation

A trailing multiple is meaningless here, and putting one in front of a reader would be a disservice. Over the last twelve months the company recorded a pre-tax loss of about 1.35 billion dollars. Dividing a share price by that produces nothing. The only sensible read applies the company's own through-the-cycle margins, about 3.6%, to the current revenue base of roughly $39.3 billion, which puts normalized operating profit near 1.45 billion dollars.

On that basis the market is paying about twenty-four times, which embeds something close to 5.7% annual growth in that normalized profit, held for five years. Two things about that number deserve caution. It is sensitive to the discount rate to an unusual degree, moving roughly 8.5 percentage points for each additional percentage point of cost of capital, and the comparison base for judging how unusual it is happens to be thin for a company of this shape. Treat it as a direction, not a measurement.

What is unambiguous is where the methods land. Every family sits below today's price. The asset lens does: book value is $21.14 a share against a market price of $29.85. The comparable-multiple lenses do. So does the forward lens. That is the strongest statement this framework makes about any company, and it means the price is not defended by any standard frame. It is defended only by a view about the cycle, which is a legitimate view and an unhedged one.

Cohort comparison adds less than usual, because the cohort is in the same hole. LYB, the closest large comparable, ran a negative 1.0% operating margin on $29.7 billion of revenue with revenue down 9.4% year over year. WLK ran negative 15.7%, CE negative 7.8%, HUN negative 3.3%. The only member of this group earning proper returns is LIN, at a 26.5% operating margin on $34.7 billion of revenue, and industrial gases is a different business with take-or-pay contracts underneath it, not a comparison Dow can be held to.

The balance sheet is where the analysis has to end, because it sets the deadline. Borrowings gross of cash run near 16.3 billion dollars against liquid assets near 4.1 billion dollars, and the net figure sits at roughly 8.4 times through-cycle operating profit. Coverage of about 1.7 times on that same normalized basis is thin, and it is thinner still against the trailing year, which produced no profit to cover anything. Share count has drifted down about 0.6% a year across four years, so dilution is not adding to the problem. The question the price is really asking is not whether Dow survives the trough. It is how many more quarters of trough the balance sheet can absorb before the recovery has to start paying for itself.

Catalysts

The March 2026 quarter is the reference point for how far the cycle has actually turned. Net loss available to Dow Inc. common stockholders came to $533 million against $307 million in the comparable quarter, and the driver was not the plants: segment operating profit on the company's own measure ran $208 million in packaging and specialty plastics and $117 million in performance materials and coatings, against a $118 million loss in industrial intermediates, netting to $154 million after corporate costs. Currency added about 3 percent to net sales, volume rose 9 percent in Latin America and fell 4 percent in the U.S. and Canada, and local price in performance materials and coatings rose 2 percent while industrial intermediates fell 4 percent.

The equity-method line is the live risk. Losses from nonconsolidated affiliates inside industrial intermediates reached $242 million in the quarter, up from $58 million, with the filing pointing to lower licensing revenue and the conflict in the Middle East. That line has no cost programme attached to it and no obvious timetable, so it is the item most likely to decide whether the next few prints improve.

Two structural actions are still working through. The restructuring announced on July 7, 2025, approved by the board on June 30, 2025, rationalizes the global asset footprint, and the March 2026 filing sets out a wider simplification programme covering processes and cost structure. Separately, the new polyethylene train on the U.S. Gulf Coast came online in the second half of 2025, so 2026 carries its first full year of output at a moment when polyethylene volume is expected to grow even as price has not recovered. Volume arriving before price is the normal order of a chemicals recovery, and it is the sequence to check against each quarterly print.

Peer Cohorts (Per Segment, With Filing Citations)

Packaging & Specialty Plastics (reported)

• LYB (LYONDELLBASELL INDUSTRIES N.V.)
• FY2025 10-K: …well as smaller specialty applications. Our customers use our plastics and chemicals to manufacture a wide range of products that people use in their everyday lives, including food packaging, home furnishings, automotive components, paints and coatings. We also develop and license chemical and polyolefin process…
• FY2025 10-K: …customer service and potential substitute materials. Profitability is affected by the worldwide level of demand along with price competition, which may intensify due to, among other things, new industry capacity and industry outages. Demand growth could be impacted by further development of alternative bio-based…
• WLK (Westlake Corporation)
• FY2025 10-K: …outdoor living products include Zuri ® Premium Decking. PVC Pipe. We manufacture and sell PVC pipe ranging in sizes from ½ inch to 36 inches in diameter, in gasketed, solvent welded, and restrained joint configurations. Our pipe products are used in residential water and sewer applications; municipal potable water…
• FY2025 10-K: …commercial installations; molded gasketed and solvent weld sewer fittings up to 12 inches, molded gasketed municipal pressure fittings and molded fittings for the pool, spa, industrial markets and electrical assemblies; and fabricated custom fittings up to 36 inches for municipal and plumbing installations. We…
• CE (CELANESE CORPORATION)
• FY2025 10-K: Asia and consist of 51 global production facilities and an additional 20 strategic affiliate production facilities. As of December 31, 2025, we employed 11,434 people worldwide. Business Segment Overview We operate principally through two business segments: Engineered Materials and the Acetyl Chain. See Business…
• FY2025 10-K: …additional downgrades; • volatility or changes in the price and availability of raw materials and energy, particularly changes in the demand for, supply of, and market prices of ethylene, methanol, natural gas, carbon monoxide, wood pulp, hexamethylene diamine, Polyamide 66 ("PA66"), polybutylene terephthalate,…
• EMN (EASTMAN CHEMICAL CO)
• FY2025 10-K: Eastman's strategy is to target industries and markets where the Company can leverage its application development expertise to develop product offerings to provide differentiated value that addresses current and future customer and market needs. The Company's strategic marketing approach and capabilities leverage the…
• FY2025 10-K: …and assess performance of the Company. The CODM evaluates segment operating performance, and makes resource allocation and performance evaluation decisions, based on Adjusted EBIT, defined as the GAAP measure earnings before interest and taxes ("EBIT"), adjusted for non-core, unusual, or non-recurring items. These…
• OLN (Olin Corporation)
• FY2025 10-K: …the Chlor Alkali Products and Vinyls segment to generate caustic soda production and sales. Chlorine and caustic soda used in our Epoxy segment are transferred at cost from the Chlor Alkali Products and Vinyls segment. The following table lists the principal products and services of our Epoxy segment: Products &…
• FY2025 10-K: …treatment activities are higher. Our Epoxy segment also serves a number of applications which experience their highest level of activity during the spring and summer months, particularly civil engineering and protective coatings and other construction materials, including composites and flooring. RAW MATERIALS Basic…
• DD (DUPONT DE NEMOURS, INC.)
• FY2025 10-K: …and a commitment to quality and performance makes Healthcare & Water Technologies a preferred choice for customers seeking to develop their next-generation products. Acquisitions On August 1, 2023, the Company completed the acquisition of Spectrum Plastics Group ("Spectrum") from AEA Investors. Spectrum is a…
• FY2025 10-K: …practices, pricing strategies, customer services and a changing regulatory landscape. The Company provides its customers with extensive support and technical and testing services, in addition to new product development informed by specific industry technological, sustainability and regulatory needs and evolving…
• IFF (INTERNATIONAL FLAVORS & FRAGRANCES INC)
• FY2025 10-K: …development team partners with our scientists and researchers to optimize consumer appeal and relevance of our product offerings. This collaborative process ensures offerings are refined and ready for integration into final consumer products. Beyond creating new products, our teams advise customers on improving…
• FY2025 10-K: …pet food and feed additives. Food Ingredients also includes savory solutions (such as spices, marinades, and mixtures) and inclusion products (such as products combining flavorings with fruit, vegetables and other natural ingredients). Health & Biosciences Our Health & Biosciences segment consists of the development…
• LIN (LINDE PLC)
• FY2025 10-K: …oxygen and nitrogen generally have a relatively small distribution radius from the plants at which they are produced. Merchant argon, hydrogen and helium can be shipped much longer distances. The customer agreements used in the merchant business are usually three to seven-year requirement contracts. Packaged Gases.…
• FY2025 10-K: …have a relatively small distribution radius from the plants at which they are produced. Merchant argon, hydrogen and helium can be shipped much longer distances. The customer agreements used in the merchant business are usually three to seven year supply agreements based on the requirements of the customer. These…

Industrial Intermediates & Infrastructure (reported)

• LYB (LYONDELLBASELL INDUSTRIES N.V.)
• FY2025 10-K: …risks through contractual limitations of liability and indemnities and through insurance may not always be effective. As a result, our financial condition and results of operation would be adversely affected, and other companies with competing technologies may have the opportunity to secure a competitive advantage.…
• FY2025 10-K: …our first quarter of 2026 operating rates with global demand and plan to operate our O&P-Americas, O&P-EAI and I&D assets at approximately 85%, 75% and 85%, respectively. RELATED PARTY TRANSACTIONS We have related party transactions with our joint ventures. We believe that such transactions are affected on terms…
• OLN (Olin Corporation)
• FY2025 10-K: …regulations in the future. If we are delayed or unable to ship finished products or unable to obtain raw materials as a result of any such new or modified regulations or public policy changes related to transportation safety, or these transportation companies' failure to operate properly, or if there are significant…
• FY2025 10-K: …computed on a straight-line basis over the estimated useful lives of the related assets. Interest costs incurred to finance expenditures for major long-term construction projects are capitalized as part of the historical cost and included in property, plant and equipment and are depreciated over the useful lives 57…
• CE (CELANESE CORPORATION)
• FY2025 10-K: Asia and consist of 51 global production facilities and an additional 20 strategic affiliate production facilities. As of December 31, 2025, we employed 11,434 people worldwide. Business Segment Overview We operate principally through two business segments: Engineered Materials and the Acetyl Chain. See Business…
• FY2025 10-K: …where growth is driven by increasing new project commercializations from the pipeline. Our project pipeline model leverages competitive advantages that include our global assets and resources, marketplace presence, broad materials portfolio and differentiated capabilities. Our global assets and resources are…
• EMN (EASTMAN CHEMICAL CO)
• FY2025 10-K: …divested businesses, non-operational sites and product lines, and discontinued programs. (6) Segment assets include accounts receivable, inventory, fixed assets, goodwill, and intangible assets. 109 Table of Contents NOTES TO THE AUDITED CONSOLIDATED FINANCIAL STATEMENTS For year ended December 31, 2023 (Dollars in…
• FY2025 10-K: …of hostilities or terrorism, cyber-attacks, or breakdown or degradation of transportation and supply chain infrastructure used for delivery of supplies to the Company or for delivery of products to customers. Unplanned disruptions of manufacturing operations or related infrastructure could be significant in scale and…
• HUN (Huntsman Corporation)
• FY2025 10-K: …representative customers, raw materials and representative competitors of each of our business segments: Product lines End markets / applications Representative customers Raw materials Representative competitors Polyurethanes MDI Polyurethane chemicals are used to produce rigid and flexible foams, as well as…
• FY2025 10-K: …aluminum panels and other steel materials to lighten structures in aerospace, automotive and other transportation. Our Advanced Materials segment is characterized by the breadth of our product offering, our expertise in complex chemistry, our long-standing relationships with our customers, our ability to develop and…

Performance Materials & Coatings (reported)

• AVNT (AVIENT CORPORATION)
• FY2025 10-K: …are primarily customer receivables, inventories, net property, plant and equipment, intangible assets and goodwill. Corporate assets and liabilities primarily include cash, debt, pension and other employee benefits, environmental liabilities, and other unallocated corporate assets and liabilities. The accounting…
• FY2025 10-K: …reduced energy use, light weighting, and renewable energy applications. Our colorant and additives concentrates are used in a broad range of polymers, including those used in medical and pharmaceutical devices, food packaging, personal care and cosmetics, transportation, building products, wire and cable markets. We…
• CE (CELANESE CORPORATION)
• FY2025 10-K: …and withstanding deformation. Nylon compounds are used in a range of applications including automotive, consumer, electrical, electronic and industrial. These value-added applications in diverse end uses support the business' global growth objectives. POM, PBT and LFRT are used in a broad range of…
• FY2025 10-K: …as well as the manner in which the information is used internally by the Company's chief operating decision maker ("CODM"), who is the Company's President and Chief Executive Officer. The Company's CODM regularly reviews the Operating profit of each reportable segment to assess financial results and allocate…
• EMN (EASTMAN CHEMICAL CO)
• FY2025 10-K: …polymers, films, and plastics with differentiated performance properties for value-added end-uses in transportation; durables and electronics; building and construction; medical and pharma; and consumables end-markets. Key technology platforms for this segment include cellulosic biopolymers, copolyesters, and PVB and…
• FY2025 10-K: …and assess performance of the Company. The CODM evaluates segment operating performance, and makes resource allocation and performance evaluation decisions, based on Adjusted EBIT, defined as the GAAP measure earnings before interest and taxes ("EBIT"), adjusted for non-core, unusual, or non-recurring items. These…
• HUN (Huntsman Corporation)
• FY2025 10-K: …aluminum panels and other steel materials to lighten structures in aerospace, automotive and other transportation. Our Advanced Materials segment is characterized by the breadth of our product offering, our expertise in complex chemistry, our long-standing relationships with our customers, our ability to develop and…
• FY2025 10-K: …representative customers, raw materials and representative competitors of each of our business segments: Product lines End markets / applications Representative customers Raw materials Representative competitors Polyurethanes MDI Polyurethane chemicals are used to produce rigid and flexible foams, as well as…
• CC (Chemours Co)
• FY2025 10-K: …temperature stability, and unique di-electric properties. Our Advanced Performance Materials segment has a diversified offering of products that includes various specialty product solutions, membranes, industrial resins, and coatings across our Teflon TM , Viton TM , Krytox TM , and Nafion TM brand portfolios. These…
• FY2025 10-K: …the cyclicality of key end markets, such as industrial, chemical processing, consumer goods, and transportation, and is expected to grow in line with GDP. However, with growing demand for cleaner and faster technologies, demand for products in the performance solutions portfolio is expected to grow at a rate faster…
• ROG (Rogers Corporation)
• FY2025 10-K: …the loss of any one of our larger customers would require a period of adjustment, during which the results of operations could be materially adversely impacted, we believe that such events could be successfully mitigated over a period of time due to the diversity of our customer base. We employ a technical sales and…
• FY2025 10-K: …we are exposed to market fluctuations in commodity pricing as we utilize certain materials, such as copper and ceramic, which are key materials in certain of our products. In order to minimize the risk of market-driven price changes in these commodities, we utilize hedging strategies to insulate us against price…

Methodology Note

• Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
• Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
• Economic-unit decomposition (SOTP): each disclosed business unit is assigned its native valuation basis before any multiple is applied. Operating units are valued on enterprise value; funded financial units are valued on their own common equity, because their borrowings fund earning assets rather than levering the parent. A company total is stated only once every material unit carries a supported value and the parent capital bridge reconciles.
• Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
• Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.